Anti-Remodeling Cardiac Therapy in Patients With Duchenne Muscular Dystrophy, Meta-Analysis Study

Background: Almost all Duchenne muscular dystrophy (DMD) patients that reach their 30s present cardiomyopathy. As a result, this population remains under-treated. There is no sufficient proof of the efficacy of anti-remodeling cardiac therapy for DMD cardiomyopathy (DMDCM). We aim to assess the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Raccah, Bruria Hirsh, Biton, Bar, Amir, Offer, Gotsman, Israel, Nahman, Dean, Matok, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811374/
https://www.ncbi.nlm.nih.gov/pubmed/35126112
http://dx.doi.org/10.3389/fphar.2021.769896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811374/
https://www.ncbi.nlm.nih.gov/pubmed/35126112
http://dx.doi.org/10.3389/fphar.2021.769896

Ejemplares similares